News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
273,758 Results
Type
Article (22552)
Company Profile (60)
Press Release (251143)
Multimedia
Podcasts (24)
Webinars (9)
Section
Business (60733)
Career Advice (1256)
Deals (10390)
Drug Delivery (70)
Drug Development (43383)
Employer Resources (123)
FDA (7359)
Job Trends (6328)
News (123004)
Policy (13051)
Tag
Academia (1712)
Accelerated approval (10)
Adcomms (13)
Allergies (71)
Alliances (17089)
ALS (67)
Alzheimer's disease (725)
Antibody-drug conjugate (ADC) (135)
Approvals (7414)
Artificial intelligence (167)
Autoimmune disease (44)
Automation (13)
Bankruptcy (77)
Best Places to Work (5663)
BIOSECURE Act (10)
Biosimilars (38)
Biotechnology (41)
Bladder cancer (102)
Brain cancer (31)
Breast cancer (331)
Cancer (2589)
Cardiovascular disease (214)
Career advice (1090)
Career pathing (23)
CAR-T (130)
CDC (21)
Cell therapy (348)
Cervical cancer (25)
Clinical research (36318)
Collaboration (532)
Company closure (1)
Compensation (108)
Complete response letters (22)
COVID-19 (1346)
CRISPR (49)
C-suite (158)
Cystic fibrosis (81)
Data (3029)
Decentralized trials (2)
Denatured (1)
Depression (34)
Diabetes (379)
Diagnostics (3211)
Digital health (13)
Diversity (3)
Diversity, equity & inclusion (35)
Drug discovery (100)
Drug pricing (101)
Drug shortages (25)
Duchenne muscular dystrophy (85)
Earnings (22957)
Editorial (29)
Employer branding (13)
Employer resources (108)
Events (40309)
Executive appointments (299)
FDA (8637)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (456)
Gene editing (102)
Generative AI (14)
Gene therapy (279)
GLP-1 (660)
Government (2508)
Grass and pollen (3)
Guidances (186)
Healthcare (8987)
HIV (15)
Huntington's disease (16)
IgA nephropathy (47)
Immunology and inflammation (87)
Immuno-oncology (9)
Indications (34)
Infectious disease (1445)
Inflammatory bowel disease (78)
Inflation Reduction Act (10)
Influenza (49)
Intellectual property (83)
Interviews (236)
IPO (4935)
IRA (31)
Job creations (923)
Job search strategy (917)
Kidney cancer (10)
Labor market (31)
Layoffs (148)
Leadership (21)
Legal (2160)
Liver cancer (53)
Longevity (7)
Lung cancer (369)
Lymphoma (197)
Machine learning (14)
Management (48)
Manufacturing (222)
MASH (78)
Medical device (4995)
Medtech (5009)
Mergers & acquisitions (5792)
Metabolic disorders (785)
Multiple sclerosis (49)
NASH (9)
Neurodegenerative disease (79)
Neuropsychiatric disorders (17)
Neuroscience (1141)
NextGen: Class of 2025 (3075)
Non-profit (2805)
Now hiring (5)
Obesity (361)
Opinion (151)
Ovarian cancer (99)
Pain (64)
Pancreatic cancer (121)
Parkinson's disease (91)
Partnered (14)
Patents (133)
Patient recruitment (151)
Peanut (25)
People (18111)
Pharmaceutical (15)
Pharmacy benefit managers (15)
Phase I (11129)
Phase II (15522)
Phase III (12623)
Pipeline (1496)
Policy (140)
Postmarket research (1624)
Preclinical (5126)
Press Release (21)
Prostate cancer (123)
Psychedelics (10)
Radiopharmaceuticals (109)
Rare diseases (357)
Real estate (1606)
Recruiting (43)
Regulatory (10151)
Reports (27)
Research institute (1470)
Resumes & cover letters (160)
Rett syndrome (2)
RNA editing (8)
RSV (24)
Schizophrenia (62)
Series A (81)
Series B (54)
Service/supplier (3)
Sickle cell disease (49)
Special edition (16)
Spinal muscular atrophy (128)
Sponsored (27)
Startups (1185)
Stomach cancer (9)
Supply chain (37)
Tariffs (33)
The Weekly (23)
Vaccines (418)
Venture capital (31)
Weight loss (242)
Women's health (24)
Worklife (15)
Date
Today (85)
Last 7 days (462)
Last 30 days (1409)
Last 365 days (13489)
2025 (11438)
2024 (15575)
2023 (17453)
2022 (25061)
2021 (25782)
2020 (24666)
2019 (21275)
2018 (15648)
2017 (12791)
2016 (12353)
2015 (14015)
2014 (9720)
2013 (7943)
2012 (8204)
2011 (8909)
2010 (7915)
Location
Africa (336)
Alabama (45)
Alaska (6)
Arizona (78)
Arkansas (7)
Asia (15272)
Australia (2822)
California (4014)
Canada (1250)
China (447)
Colorado (155)
Connecticut (195)
Delaware (140)
Europe (34330)
Florida (687)
Georgia (105)
Hawaii (1)
Idaho (21)
Illinois (336)
India (22)
Indiana (252)
Iowa (8)
Japan (174)
Kansas (40)
Kentucky (25)
Louisiana (10)
Maine (17)
Maryland (553)
Massachusetts (2916)
Michigan (113)
Minnesota (187)
Mississippi (3)
Missouri (50)
Montana (12)
Nebraska (14)
Nevada (45)
New Hampshire (22)
New Jersey (1263)
New Mexico (11)
New York (1070)
North Carolina (566)
North Dakota (6)
Northern California (1900)
Ohio (103)
Oklahoma (6)
Oregon (13)
Pennsylvania (658)
Puerto Rico (5)
Rhode Island (15)
South America (529)
South Carolina (35)
Southern California (1585)
Tennessee (87)
Texas (580)
United States (14645)
Utah (109)
Virginia (134)
Washington D.C. (49)
Washington State (350)
West Virginia (1)
Wisconsin (38)
Wyoming (1)
273,758 Results for "american type culture collection atcc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bayer to Present New Data for KERENDIA® (finerenone) in People with Chronic Kidney Disease and Type 1 or Type 2 Diabetes at American Society of Nephrology (ASN) Kidney Week 2025
November 3, 2025
·
8 min read
Press Releases
ATCC Secures OASIS+ Multi-Agency Contract Vehicle from GSA
June 24, 2025
·
2 min read
Press Releases
Align Announces New Collaboration with ATCC to Bring AI-Ready Microbial Datasets to Life
June 18, 2025
·
4 min read
Regulatory
After FDA Rejection, Lexicon’s Type 1 Diabetes Drug Hit With Another Regulatory Delay
An advisory committee last year found that Zynquista’s benefit-risk profile in type 1 diabetes was unfavorable due to cases of diabetic ketoacidosis.
September 23, 2025
·
1 min read
·
Tristan Manalac
Press Releases
ATCC Announces New Executive Leadership Appointments
April 22, 2025
·
5 min read
Press Releases
OS Therapies Granted Final Type C Meeting by U.S. FDA and pre-MAA Meeting by U.K. MHRA for OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
Final FDA Type C Meeting December 11, 2025 - biomarker data to be available October 10, 2025 FDA/Osteosarcoma Institute Workshop narrows focus for OST-HER2 overall survival, biomarker correlation & canine osteosarcoma data
October 17, 2025
·
5 min read
Drug pricing
How the American Pharma Industry Became the ‘Bad Guys’
Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry hold the same respect as steelworkers or other all-American pursuits?
August 20, 2025
·
6 min read
·
Annalee Armstrong
Press Releases
Vertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific Sessions
June 23, 2025
·
9 min read
Press Releases
Endogenex to Present Data on Endoscopic Procedure for Type 2 Diabetes at American Diabetes Association’s (ADA) 85th Scientific Sessions
June 17, 2025
·
2 min read
Press Releases
ATCC Appoints Dr. Ruth Cheng as New President and Chief Executive Officer
January 17, 2025
·
4 min read
1 of 27,376
Next
